Past performance does not predict future results. Informational only, not investment advice.
Blackford Quentin S. (President and CEO at iRhythm Holdings, Inc.) reported an open-market sale of 26,859 shares of IRTC at an average $124.65, roughly $3,348,012, in a Form 4 filed 2026-08-11.
Murphy Patrick Michael (CBO and CLO at iRhythm Holdings, Inc.) reported an open-market sale of 7,093 shares of IRTC at an average $124.65, roughly $884,156, in a Form 4 filed 2026-08-11.
Patterson Chad (CHIEF COMM & PRODUCT OFFICER at iRhythm Holdings, Inc.) reported an open-market sale of 7,093 shares of IRTC at an average $124.65, roughly $884,170, in a Form 4 filed 2026-08-11.
Shrishrimal Sumi (EVP, Chief Risk Officer at iRhythm Holdings, Inc.) reported an open-market sale of 5,372 shares of IRTC at an average $124.65, roughly $669,641, in a Form 4 filed 2026-08-11.
Turakhia Minang (CHIEF MED/SCI OFCR EVP ADVTECH at iRhythm Holdings, Inc.) reported an open-market sale of 7,093 shares of IRTC at an average $124.65, roughly $884,151, in a Form 4 filed 2026-08-11.
End of results.